Marpai Inc (NASDAQ: MRAI) stock fell -5.97% on Monday to $0.91 against a previous-day closing price of $0.97. With 1.62 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.53 million shares. During the session, the Healthcare Plans company that operates in wider Healthcare sector, reached to the highest price of $0.9800 whereas the lowest price it dropped to was $0.8801. The 52-week range on MRAI shows that it touched its highest point at $13.60 and its lowest point at $0.33 during that stretch. It currently has a 1-year price target of $6.00. Beta for the stock currently stands at 2.23.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MRAI was up-trending over the past week, with a rise of 42.19%, but this was up by 69.93% over a month. Three-month performance dropped to -18.02% while six-month performance fell -68.17%. The stock lost -79.87% in the past year, while it has lost -68.40% so far this year.
Float and Shares Shorts:
At present, 5.32 million MRAI shares are outstanding with a float of 5.27 million shares on hand for trading. On Oct 30, 2023, short shares totaled 0.29 million, which was 3.70% higher than short shares on Sep 28, 2023. In addition to Mr. Edmundo Gonzalez as the firm’s Co-Founder, Secretary & Director, Mr. Yaron I. Eitan serves as its Co-Founder & Chairman of the Board.
Other institutions hold 9.51% of MRAI, in contrast to 4.20% held by mutual funds. Shares owned by individuals account for 1.76%. As the largest shareholder in MRAI with 3.83% of the stake, Sabby Management LLC holds 299,077 shares worth 299,077. A second-largest stockholder of MRAI, The Vanguard Group, Inc., holds 118,608 shares, controlling over 1.52% of the firm’s shares. Geode Capital Management LLC is the third largest shareholder in MRAI, holding 33,129 shares or 0.43% stake. With a 0.70% stake in MRAI, the Vanguard Extended Market Index Fu is the largest stakeholder. A total of 54,324 shares are owned by the mutual fund manager. The Vanguard Total Stock Market ETF, which owns about 0.64% of MRAI stock, is the second-largest Mutual Fund holder. It holds 49,896 shares valued at 20058.0. Fidelity Extended Market Index Fu holds 0.38% of the stake in MRAI, owning 29,399 shares worth 11818.0.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for MRAI since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With MRAI analysts setting a high price target of $6.00 and a low target of $6.00, the average target price over the next 12 months is $6.00. Based on these targets, MRAI could surge 559.34% to reach the target high and rise by 559.34% to reach the target low. Reaching the average price target will result in a growth of 559.34% from current levels.
Summary of Insider Activity:
Insiders traded MRAI stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has risen to 1 over the past year. The total number of shares bought during that period was 0 while 140,614 shares were sold.